Tiedemann Advisors, LLC Procept Bio Robotics Corp Transaction History
Tiedemann Advisors, LLC
- $2.31 Billion
- Q3 2023
A detailed history of Tiedemann Advisors, LLC transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Tiedemann Advisors, LLC holds 73,388 shares of PRCT stock, worth $5.25 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
73,388
Previous 86,236
14.9%
Holding current value
$5.25 Million
Previous $3.05 Million
21.03%
% of portfolio
0.1%
Previous 0.13%
Shares
2 transactions
Others Institutions Holding PRCT
# of Institutions
273Shares Held
39.4MCall Options Held
262KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA4.84MShares$347 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$249 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.53MShares$110 Million0.04% of portfolio
-
Loomis Sayles & CO L P1.24MShares$89 Million0.13% of portfolio
-
State Street Corp Boston, MA1.18MShares$84.4 Million0.0% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $3.19B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...